IN THE RACE to get “shots into arms,” vaccine producers are literally trying to squeeze out more RNA from the manufacturing process. Enter Ginkgo Bioworks, Boston’s biotechnology giant, whose technology […]
IN THE RACE to get “shots into arms,” vaccine producers are literally trying to squeeze out more RNA from the manufacturing process. Enter Ginkgo Bioworks, Boston’s biotechnology giant, whose technology […]